LVRNA009

· AIM Vaccine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LVRNA009, covering 2023-02-02 to 2023-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of SARS-CoV-2 mRNA Vaccine(LVRNA009) as Heterologous Booster in Islamabad [Phase 3]